U.S. markets open in 4 hours 38 minutes

LifeVantage Corporation (L2T1.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
3.6400+0.0600 (+1.68%)
As of 08:08AM CET. Market open.
Full screen
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close3.5800
Bid3.6400 x 150000
Ask3.7800 x 150000
Day's Range3.6400 - 3.6400
52 Week Range3.5400 - 6.2000
Avg. Volume28
Market Cap46.86M
Beta (5Y Monthly)1.12
PE Ratio (TTM)91.00
EPS (TTM)0.0400
Earnings DateJan 30, 2023 - Feb 03, 2023
Forward Dividend & Yield0.11 (3.22%)
Ex-Dividend DateNov 30, 2022
1y Target Est7.50
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value

Subscribe to Yahoo Finance Plus to view Fair Value for L2T1.F

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
    View more
    • Simply Wall St.

      We Wouldn't Be Too Quick To Buy LifeVantage Corporation (NASDAQ:LFVN) Before It Goes Ex-Dividend

      Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see LifeVantage...

    • GlobeNewswire

      LifeVantage Declares Quarterly Dividend

      SALT LAKE CITY, Nov. 02, 2022 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN) today announced that the Company’s Board of Directors has approved a quarterly cash dividend of $0.03 per share of common stock, which will be paid December 15, 2022 to all stockholders of record at the close of business on December 1, 2022. About LifeVantage Corporation LifeVantage Corporation (Nasdaq: LFVN) is a pioneer in nutrigenomics, the study of how nutrition and naturally occurring compounds affect hu

    • GlobeNewswire

      LifeVantage Announces Financial Results for the First Quarter of Fiscal 2023

      SALT LAKE CITY, Nov. 02, 2022 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN) today reported financial results for its first fiscal quarter ended September 30, 2022. First Quarter Fiscal 2023 Summary*: Revenue of $51.8 million, a decrease of 2.7% from the prior year period. Excluding the negative impact of foreign currency fluctuations, first quarter revenue was up approximately 2.3%;Revenue in the Americas decreased 0.2%. Revenue in the United States increased 1.1%. Revenue in Asia/P